Dihydropyrimidine based Hydrazine dihydrochloride (cas 5341-61-7) derivatives as potent urease inhibitors

Add time:07/12/2019    Source:sciencedirect.com

Four series of heterocyclic compounds 4-dihydropyrimidine-2-thiones 7–12 (series A), N,S-dimethyl-dihydropyrimidines 13–18 (series B), hydrazine derivatives of dihydropyrimidine 19–24 (series C), and tetrazolo dihydropyrimidine derivatives 25–30 (series D), were synthesized and evaluated for in vitro urease inhibitory activity. The series B–D were first time examined for urease inhibition. Series A and C were found to be significantly active with IC50 values between 34.7–42.9 and 15.0–26.0 μM, respectively. The structure–activity relationship showed that the free S atom and hydrazine moiety are the key pharmacophores against urease enzyme. The kinetic studies of the active series A (7–12) and C (19–24) were carried out to determine their modes of inhibition and dissociation constants Ki. Compounds of series A (7–12) and series C (19–24) showed a mixed-type of inhibition with Ki values ranging between 15.76–25.66 and 14.63–29.42 μM, respectively. The molecular docking results showed that all the active compounds of both series have significant binding interactions with the active sites specially Ni-ion of the urease enzyme. Cytotoxicity of all series A–D was also evaluated against mammalian mouse fibroblast 3T3 cell lines, and no toxicity was observed in cellular model.

We also recommend Trading Suppliers and Manufacturers of Hydrazine dihydrochloride (cas 5341-61-7). Pls Click Website Link as below: cas 5341-61-7 suppliers

Prev:Ligand based design and synthesis of pyrazole based derivatives as selective COX-2 inhibitors
Next:Simultaneous reduction and surface functionalization of graphene oxide by cystamine dihydrochloride for rubber composites)